FrancophonIA/ELRC3.0 huggingface dataset:
English: Umeclidinium bromide plasma elimination half-life following inhaled dosing for 10 days averaged 19 hours, with 3% to 4% active substance excreted unchanged in urine at steady-state.
Croatian: Poluvrijeme eliminacije umeklidinijeva bromida iz plazme nakon inhalacijske primjene tijekom 10 dana u prosjeku je iznosilo
English: In a Phase III, 6-month study (DB2113373) Rolufta Ellipta provided a clinically meaningful improvement over placebo in lung function (as measured by forced expiratory volume in 1 second [FEV1]) over 24 hours following once daily administration, which was evident at 30 minutes following administration of the first dose (improvement over placebo by 102 mL, p<0.001*).
Croatian: [FEV1]) u odnosu na placebo tijekom 24 sata nakon primjene jedanput na dan, što je bilo primjetno 30 minuta nakon primjene prve doze (poboljšanje za 102 ml u odnosu na placebo, p<0,001*).
English: Nasopharyngitis Upper respiratory tract infection Urinary tract infection Sinusitis
Croatian: Infekcije i infestacije nazofaringitis infekcija gornjeg dišnog sustava infekcija mokraćnog sustava sinusitis faringitis često često često često manje često
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING INTERMEDIATE OUTER CARTON (WITHOUT BLUE BOX- MULTIPACK ONLY) 55 micrograms
Croatian: MEĐUPAKIRANJE (BEZ PLAVOG OKVIRA - SAMO VIŠESTRUKO PAKIRANJE)
English: GlaxoSmithKline Slovakia s. r. o. Tel: + 421 (0)2 48 26 11 11 recepcia.sk@gsk.com
Croatian: Tel: + 421 (0)2 48 26 11 11 recepcia.sk@gsk.com
English: Headache Dysgeusia Dizziness
Croatian: Egzacerbacije KOPB-a
English: In two 12-week, placebo controlled studies (200109 and 200110), the addition of Rolufta Ellipta to fluticasone furoate/vilanterol (FF/VI) (92/22 micrograms) once daily in adult patients with a clinical diagnosis of COPD, resulted in statistically significant and clinically meaningful improvements in the primary endpoint of trough FEV1 at Day 85 compared to placebo plus FF/VI (124 mL 95% CI: 93, 154; p<0.001 and 122 mL 95% CI: 91, 152; p<0.001).
Croatian: U dva 12-tjedna, placebom kontrolirana ispitivanja (200109 i 200110), dodavanje lijeka Rolufta Ellipta kombinaciji flutikazonfuorat/vilanterol (FF/VI) (92/22 mikrograma) jedanput dnevno, u odraslih bolesnika s kliničkom dijagnozom KOPB-a, ishodilo je statistički značajnim i kliničkim bitnim
English: The “Discard by” date is 6 weeks from the date you opened the tray.
Croatian: Datum kad je lijek potrebno baciti je 6 tjedana od datuma otvaranja podloška.
English: The “Discard by” date should be written on the inhaler label in the space provided.
Croatian: Datum kad je lijek potrebno baciti mora se napisati u predviđeno mjesto na naljepnici inhalatora.
English: In use shelf-life: 6 weeks.
Croatian: Rok valjanosti nakon otvaranja: 6 tjedana.
English: Rare side effects
Croatian: Rijetke nuspojave
English: Breathlessness:
Croatian: Nedostatak zraka:
English: Each single inhalation provides a delivered dose (the dose leaving the mouthpiece of the inhaler) of 55 micrograms umeclidinium (equivalent to 65 micrograms of umeclidinium bromide) This corresponds to a pre-dispensed dose of 62.5 micrograms umeclidinium equivalent to 74.2 micrograms umeclidinium bromide.
Croatian: Jedna pojedinačna inhalacija osigurava primijenjenu dozu (doza koja izlazi iz nastavka za usta na inhalatoru) od 55 mikrograma umeklidinija (što odgovara količini od 65 mikrograma umeklidinijeva bromida).
English: GlaxoSmithKline Kft. Tel.: + 36 1 225 5300
Croatian: GlaxoSmithKline d.o.o. Tel: +385 1 6051999
English: Tel: + 420 222 001 111 cz.info@gsk.com
Croatian: GlaxoSmithKline, s.r.o. Tel: + 420 222 001 111 cz.info@gsk.com
English: If you get any side effects, talk to your doctor, pharmacist or nurse.
Croatian: Ako primijetite bilo koju nuspojavu, potrebno je obavijestiti liječnika, ljekarnika ili medicinsku sestru.
English: It may harm them, even if their signs of illness are the same as yours.
Croatian: Može im naškoditi, čak i ako su njihovi znakovi bolesti jednaki Vašima.
English: How to use Rolufta Ellipta
Croatian: Kako primjenjivati lijek Rolufta Ellipta
English: PC: SN: NN:
Croatian: PC:
English: Contents of the pack and other information
Croatian: Sadržaj pakiranja i druge informacije Što Rolufta Ellipta sadrži
English: • dry mouth
Croatian: Sredstvo za sušenje
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS FOIL LAMINATE TRAY LID
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP POKLOPAC PODLOŠKA OD VIŠESLOJNE FOLIJE 55 mikrograma
English: Excipients
Croatian: OBLIK
English: Ireland.
Croatian: Irska
English: • Dizziness
Croatian: • omaglica.
English: Renal impairment
Croatian: Česte nuspojave
English: See the end of section 4 for how to report side effects.
Croatian: Za postupak prijavljivanja nuspojava, pogledajte dio 4.
English: You can help by reporting any side effects you may get.
Croatian: Prijavom svih sumnji na nuspojavu i Vi možete pomoći.
English: How to store Rolufta Ellipta
Croatian: Kako čuvati lijek Rolufta Ellipta
English: ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
Croatian: PRILOG I. SAŽETAK OPISA SVOJSTAVA LIJEKA
English: In the 12-week study, a statistically significant improvement compared with placebo in the TDI focal score at Week 12 was not demonstrated for Rolufta Ellipta (1.0 units, p=0.05).
Croatian: Transitional Dyspnoea Index, TDI) nakon 12 tjedana u usporedbi s placebom (1,0 bod; p=0,05).
English: Rolufta Ellipta demonstrated a greater improvement from baseline in weighted mean FEV1 over 0-6 hours post-dose at Week 24 compared with placebo (150 ml, p<0.001*) in the 24-week pivotal study.
Croatian: Lijek Rolufta Ellipta je postigao veće poboljšanje ponderirane srednje vrijednosti FEV1 u razdoblju od 0 do 6 sati nakon primjene doze u odnosu na početne vrijednosti u usporedbi s placebom nakon 24 tjedna
English: A statistically significant improvement compared with placebo in the TDI focal score at Week 24 was demonstrated for Rolufta Ellipta (1.0 units, p<0.001) in the 24-week study.
Croatian: U 24-tjednom ispitivanju lijek Rolufta Ellipta je doveo do statistički značajnog poboljšanja ukupnog TDI rezultata nakon 24 tjedna u usporedbi s placebom (1,0 bod; p<0,001).
English: 6.3 Shelf life
Croatian: 6.3 Rok valjanosti
English: GlaxoSmithKline, s.r.o.
Croatian: GlaxoSmithKline Slovakia s. r. o.
English: Marketing Authorisation Holder
Croatian: NOSITELJ ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET
English: Lactose monohydrate, Magnesium stearate.
Croatian: 6.1 Popis pomoćnih tvari laktoza hidrat magnezijev stearat
English: Special populations
Croatian: Posebne skupine bolesnika
English: Reporting of side effects
Croatian: Prijavljivanje nuspojava
English: 28 patches (7 x 2 mg/24h, 7 x 4 mg/24h, 7 x 6 mg/24h, 7 x 8 mg/24h)
Croatian: 28 flastera (7 x 2 mg/24h, 7 x 4 mg/24h, 7 x 6 mg/24h, 7 x 8 mg/24h)
English: Annex A
Croatian: A
English: PE/Alu/ ET copolymer/paper)
Croatian: Broj (EU) odobrenja
English: Transdermal patch Transdermal use sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)
Croatian: Transdermalni flaster
English: The recommended dose is one tablet once daily with a meal.
Croatian: Preporučena je doza jedna tableta jedanput dnevno uz obrok.
English: Further information on Juluca can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Više informacija o lijeku Juluca možete pronaći na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Both active substances are already available in the European Union: dolutegravir has been authorised since 2014 and rilpivirine has been authorised since 2011.
Croatian: Obje djelatne tvari već su dostupne u Europskoj uniji: dolutegravir je odobren od 2014., a rilpivirin je odobren od 2011.
English: What is Juluca and what is it used for?
Croatian: Što je Juluca i za što se koristi?
English: Juluca (dolutegravir / rilpivirine)
Croatian: Juluca (dolutegravir/rilpivirin)
English: Juluca must not be used with the following medicines because they may reduce its effectiveness:
Croatian: Juluca se ne smije primjenjivati u kombinaciji sa sljedećim lijekovima jer mogu smanjiti učinkovitost lijeka:
English: What measures are being taken to ensure the safe and effective use of Juluca?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Juluca?
English: The most serious side effects (which may affect up to 1 in 100) include allergic reactions that include rash or liver damage.
Croatian: Najozbiljnije nuspojave (koje se mogu pojaviti u manje od 1 na 100 osoba) jesu alergijske reakcije koje uključuju osip i oštećenje jetre.
English: • rifampicin, rifapentine (antibiotics);
Croatian: • rifampicin, rifapentin (antibiotici);
English: In this way, Juluca helps to prevent the spread of HIV-1 and keep the amount of the virus in the blood at a low level.
Croatian: Na taj način Juluca pomaže u sprečavanju širenja virusa HIV-1 i zadržava njegovu količinu u krvi na niskoj razini.
English: For more information about using Juluca, see the package leaflet or contact your doctor or pharmacist.
Croatian: Za više informacija o primjeni lijeka Juluca pogledajte uputu o lijeku ili se obratite liječniku ili ljekarniku.
English: Side effects reported with Juluca are carefully evaluated and any necessary action taken to protect patients.
Croatian: Nuspojave prijavljene za lijek Juluca pažljivo se procjenjuju i poduzimaju se potrebne mjere za zaštitu bolesnika.
English: Other information about Juluca
Croatian: Ostale informacije o lijeku Juluca
English: It does not cure HIV infection or AIDS, but it may hold off damage to the immune system and the development of infections and diseases associated with AIDS.
Croatian: Juluca ne liječi infekciju HIV-om ni AIDS, ali može odgoditi oštećenje imunosnog sustava te razvoj infekcija i bolesti povezanih s AIDS-om.
English: Why is Juluca authorised in the EU?
Croatian: Zašto je lijek Juluca odobren u EU-u?
English: What are the risks associated with Juluca?
Croatian: Koji su rizici povezani s lijekom Juluca?
English: As for all medicines, data on the use of Juluca are continuously monitored.
Croatian: Kao za sve lijekove, podatci o primjeni lijeka Juluca kontinuirano se prate.
English: It is not suitable for patients in whom any HIV medicine has stopped working or who are infected with HIV that is resistant to medicines that work in the same way as Juluca's active substances.
Croatian: Nije prikladan za bolesnike u kojih je bilo koji lijek protiv HIV-a prestao djelovati ili bolesnike zaražene virusom HIV-a rezistentnim na lijekove koji djeluju na isti način kao i djelatne tvari lijeka Juluca.
English: An overview of Juluca and why it is authorised in the EU
Croatian: Pregled informacija o lijeku Juluca i zašto je odobren u EU-u
English: Juluca is a HIV medicine used to treat adults infected with human immunodeficiency virus-1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS).
Croatian: Juluca je lijek protiv HIV-a koji se primjenjuje za liječenje odraslih osoba zaraženih virusom humane imunodeficijencije tipa 1 (HIV-1), virusom koji uzrokuje sindrom stečene imunodeficijencije (AIDS).
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Juluca have been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Juluca nalaze se u sažetku opisa svojstava lijeka i u uputi o lijeku.
English: • dexamethasone given by mouth or by injection (a steroid anti-inflammatory and immunosuppressant medicine) except when used as a single-dose treatment;
Croatian: • deksametazon koji se primjenjuje peroralno ili injekcijom (steroidni protuupalni lijek i imunosupresiv), osim ako se primjenjuje kao liječenje jednokratnom dozom;
English: • omeprazole, esomeprazole, lansoprazole, pantoprazole, rabeprazole (proton pump inhibitors for reducing stomach acid);
Croatian: • omeprazol, esomeprazol, lanzoprazol, pantoprazol, rabeprazol (inhibitori protonske pumpe za smanjivanje lučenja želučane kiseline);
English: Because Juluca does not contain an NRTI, it is free of long-term side effects caused by NRTIs.
Croatian: Budući da lijek Juluca ne sadrži NRTI, nema dugoročnih nuspojava koje uzrokuju NRTI-jevi.
English: The European Medicines Agency considered that Juluca's effectiveness was comparable to that of combination treatment with three HIV medicines that include NRTIs.
Croatian: Europska agencija za lijekove zaključila je da je učinkovitost lijeka Juluca usporediva s učinkovitošću kombiniranog liječenja trima lijekovima protiv HIV-a koji uključuju NRTI-jeve.
English: The studies involved a total of 1,028 patients whose HIV infection was well controlled for at least 6 months on a combination of three HIV medicines that included a class of HIV medicines called nucleoside (or nucleotide) reverse transcriptase inhibitors (NRTIs).
Croatian: Ispitivanjima je bilo obuhvaćeno ukupno 1028 bolesnika čija je infekcija HIV-om bila dobro kontrolirana najmanje šest mjeseci kombinacijom triju lijekova protiv HIV-a koja je uključivala skupinu lijekova protiv HIV-a naziva nukleozidni (ili nukleotidni) inhibitori reverzne transkriptaze (NRTI).
English: The most common side effects with Juluca are diarrhoea and headache.
Croatian: Najčešće nuspojave lijeka Juluca jesu proljev i glavobolja.
English: Dolutegravir, an integrase inhibitor, blocks an enzyme called integrase while rilpivirine, a non-nucleoside reverse-transcriptase inhibitor, blocks the activity of another enzyme called reverse transcriptase.
Croatian: Dolutegravir, inhibitor integraze, inhibira enzim naziva integraza, dok rilpivirin, nenukleozidni inhibitor reverzne transkriptaze, inhibira djelovanje drugog enzima naziva reverzna transkriptaza.
English: • carbamazepine, oxcarbazepine, phenobarbital, phenytoin (medicines for epilepsy);
Croatian: • karbamazepin, okskarbazepin, fenobarbital, fenitoin (lijekovi za liječenje epilepsije);
English: Juluca can only be obtained with a prescription and it should be prescribed by doctors experienced in managing HIV infection.
Croatian: Lijek Juluca izdaje se samo na liječnički recept, a treba ga propisati liječnik s iskustvom u liječenju infekcija HIV-om.
English: The proportion of patients whose viral load was below 50 copies/ml after 48 weeks was the same for patients switching compared with those remaining on the current medicines (95% in both cases).
Croatian: Udio bolesnika u kojih je nakon 48 tjedana liječenja virusno opterećenje bilo manje od 50 kopija/ml bio je isti u bolesnika koji su prešli na drugu kombinaciju lijekova i bolesnika koji su nastavili s trenutačnom kombinacijom lijekova (95 % u oba slučaja).
English: The side effects of Juluca are well known and manageable.
Croatian: Nuspojave lijeka Juluca dobro su poznate i mogu se kontrolirati.
English: How is Juluca used?
Croatian: Kako se Juluca koristi?
English: The Agency decided that Juluca's benefits are greater than its risks and it can be authorised for use in the EU.
Croatian: Agencija je zaključila da koristi lijeka Juluca nadmašuju s njim povezane rizike te da lijek može biti odobren za primjenu u Europskoj uniji.
English: How does Juluca work?
Croatian: Kako djeluje Juluca?
English: The active substances in Juluca are dolutegravir and rilpivirine.
Croatian: Djelatne tvari u lijeku Juluca jesu dolutegravir i rilpivirin.
English: What benefits of Juluca have been shown in studies?
Croatian: Koje su koristi lijeka Juluca dokazane u ispitivanjima?
English: The two active substances in Juluca, dolutegravir and rilpivirine, block the actions of enzymes that the HIV needs to make copies of itself in the cells it has infected.
Croatian: Dvije djelatne tvari u lijeku Juluca, dolutegravir i rilpivirin, inhibiraju djelovanje enzima koji su nužni za umnožavanje virusa HIV-a u zaraženim stanicama.
English: Juluca is only used for patients whose levels of HIV-1 in the blood (viral load) have been below 50 copies/ml for at least 6 months on their current HIV treatment combination.
Croatian: Juluca se primjenjuje samo u bolesnika koji na trenutačnoj kombiniranoj terapiji za liječenje infekcije HIV-om tijekom najmanje šest mjeseci imaju razinu HIV-1 u krvi (virusno opterećenje) manju od 50 kopija/ml.
English: The studies compared the effectiveness of switching to the combination of dolutegravir and rilpivirine with that of remaining on the current combination of HIV medicines.
Croatian: U ispitivanjima je učinkovitost prelaska na kombinaciju dolutegravira i rilpivirina uspoređena s nastavkom liječenja trenutačnom kombinacijom lijekova protiv HIV-a.
English: • St John's wort (a herbal medicine used for treating depression).
Croatian: • gospina trava (biljni lijek za liječenje depresije).
English: For the full list of restrictions and side effects of Juluca, see the package leaflet.
Croatian: Potpuni popis ograničenja i nuspojava vezanih uz primjenu lijeka Juluca potražite u uputi o lijeku.
English: Two main studies found that the combination of dolutegravir and rilpivirine (the active substances in Juluca) was effective for keeping HIV infection under control.
Croatian: Učinkovitost kombinacije dolutegravira i rilpivirina (djelatnih tvari lijeka Juluca) u kontroliranju infekcije HIV-om utvrđena je u dvama glavnim ispitivanjima.
English: This summary was last updated in January 2015.
Croatian: Sažetak je posljednji put ažuriran u siječnju 2015.
English: EPAR summary for the public
Croatian: EPAR, sažetak za javnost
English: This document cannot replace a face-to-face discussion with your veterinarian.
Croatian: Ovaj dokument ne može zamijeniti osobni razgovor s vašim veterinarom.
English: This is a summary of the European public assessment report.
Croatian: Ovo je sažetak europskoga javnog izvješća o procjeni.
English: The vaccine should not be handled by people with a weak immune system.
Croatian: Cjepivom ne smiju rukovati osobe sa slabim imunosnim sustavom.
English: The vaccine is given as two doses injected under the skin.
Croatian: Cjepivo se daje ubrizgavanjem dviju doza pod kožu.
English: If you need more information about your animal's medical condition or treatment, contact your veterinarian.
Croatian: Ako trebate više informacija o zdravstvenom stanju ili liječenju vaše životinje, obratite se svojem veterinaru.
English: When exposed to any of these viruses or bacteria later in life, the cat will either not become infected or have a much less serious infection.
Croatian: Kada se izloži bilo kojem od tih virusa ili bakterija kasnije u životu, mačka se ili neće zaraziti ili će imati puno manje ozbiljnu infekciju.
English: Vaccines work by ‘teaching' the immune system (the body's natural defences) how to defend itself against a disease.
Croatian: Cjepiva djeluju „učeći” imunosni sustav (prirodnu obranu tijela) kako se obraniti od bolesti.
English: If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).
Croatian: Ako želite više informacija na temelju kojih je CVMP donio svoje preporuke, pročitajte znanstvenu raspravu (također dio EPAR-a).
English: The vaccine helps to reduce the symptoms of the diseases.
Croatian: Cjepivo pomaže smanjiti simptome bolesti.
English: The first injection should be given in kittens aged at least eight weeks, with a second injection three to four weeks later.
Croatian: Prvu injekciju treba dati mačićima u dobi od najmanje osam tjedana, a drugu injekciju tri ili četiri tjedna kasnije.
English: They included young and adult cats of various breeds, but not young kittens.
Croatian: Ispitivanja su uključivala mlade i odrasle mačke različitih pasmina, ali ne i mačiće.
English: Occasionally, cats will develop temporary apathy (loss of interest in surroundings) and anorexia (loss of appetite), as well as hyperthermia (elevated body temperature) lasting for one or two days.
Croatian: Povremeno će mačke razviti privremenu apatiju (gubitak interesa za okolinu) i anoreksiju (gubitak apetita) kao i hipertermiju (povišenu tjelesnu temperaturu) koje traju dan ili dva.
English: It also helps to reduce viral excretion in case of calicivirus infection for one year after vaccination.
Croatian: Također pomaže smanjiti ekskreciju virusa u slučaju infekcije kalicivirusa na godinu dana nakon cijepljenja.
English: The antibodies will help to protect against the diseases caused by these viruses or bacteria.
Croatian: Protutijela pomažu u zaštiti protiv bolesti koje uzrokuju ti virusi i bakterije.
English: What are the precautions for the person who gives the medicine or comes into contact with the animal?
Croatian: Kojih se mjera opreza mora pridržavati osoba koja primjenjuje veterinarsko-medicinski proizvod ili dolazi u kontakt sa životinjom?
English: In the future, the immune system will be able to produce antibodies more quickly when it is again exposed to the viruses or bacteria.
Croatian: Ubuduće će imunosni sustav moći brže proizvoditi protutijela ako je izložen stvarnim virusima ili bakterijama.
English: It can also prevent death due to panleucopenia and prevent FeLV from remaining in the blood.
Croatian: Također može spriječiti uginuće životinje zbog panleukopenije te spriječiti zaostajanje FeLV-a u krvi.
English: It was not possible to detect a rise in antibodies against C. felis because of high levels of antibodies in the cats at the beginning of the study.
Croatian: Nije bilo moguće utvrditi porast protutijela protiv C. felis zbog visokih razina protutijela u mačaka na početku ispitivanja.
English: If the kitten has high levels of antibodies received from the mother in the womb and in the milk, the first vaccination should be delayed until 12 weeks of age.
Croatian: Ako mačić ima visoke razine protutijela koje je primio od majke u maternici te kroz majčino mlijeko, prvo cijepljenje treba odgoditi do dobi od 12 tjedana.
English: The canarypox viruses do not spread or multiply in the cat but they do produce proteins from the FeLV genes.
Croatian: Kanaripoks virusi ne šire se ni umnažaju u mački, no proizvode proteine iz FeLV gena.
English: There may be a local reaction at the injection site, with slight pain on touching, itching or oedema (swelling), which disappears within one or two weeks.
Croatian: Može postojati lokalna reakcija na mjestu injekcije s blagom boli prilikom dodira, svrbežom ili edemom (oticanjem) koji nestaju unutar jednog do dva tjedna.
English: The main measure of effectiveness was the level of antibodies in the blood against the viruses and bacteria in the vaccine, with the exception of the FeLV component, whose effectiveness in preventing infection had already been demonstrated in other studies.
Croatian: Glavna mjera učinkovitosti bila je razina protutijela u krvi protiv virusa i bakterija u cjepivu, uz izuzetak FeLV komponente, čija je učinkovitost u sprječavanju infekcije već pokazana u drugim ispitivanjima.
English: If self-injection does occur in these people, the doctor should be told that self-injection with a live chlamydial vaccine has occurred.
Croatian: Ako u tih osoba dođe do samoinjektiranja, liječnika treba obavijestiti da je došlo do samoinjektiranja živog cjepiva bakterija Chlamydia.
English: Information on the prescription status of this product may be found on the label/outer package.
Croatian: Informacije o tome je li za ovaj proizvod potreban veterinarski recept možete naći na etiketi/vanjskom pakiranju.
English: • inactivated (killed) calicivirosis antigens (FCV 431 and G1 strains),
Croatian: • inaktivirane (mrtve) antigene kaliciviroze (sojeve FCV 431 i G1)
English: To protect against feline leukaemia, the vaccine contains two genes from the FeLV called env and gag, which have been inserted into another vector (carrier) virus called canarypox using ‘recombinant DNA technology'.
Croatian: Sa svrhom zaštite od mačje leukemije, cjepivo sadrži dva gena iz FeLV-a koja se nazivaju env i gag, koja su umetnuta u drugi vektor (nosač) virusa koji se naziva kanaripoks s pomoću „tehnologije rekombinantne DNK”.